Every letter we have printed

Labelling changes are a poor proxy for evidence strength, since they follow regulatory process rather than publication. A label updated in one jurisdiction and not another usually reflects timing, and it is read as disagreement about the science.

Regulatory documents are public, detailed and readable, and they contain the tabulated safety data that news coverage summarises badly. Pointing readers at the primary document is more useful than another summary of it.

Anything in this area is squarely a matter for the clinician conducting the procedure, and a publication’s job is to describe what the professional guidance says and where it differs. Yours does that and stops, which is right.

A practical point about labelling for submission. Write the identifier on the tube, not on a sticker, and not on the bag. Stickers come off in cold conditions and the laboratory then has a tube with no name and a bag with no contents.

The retained-sample idea from an earlier letter belongs in this section too. If half the vial stays sealed with the buyer and half goes to the laboratory, a disputed result has a physical answer rather than a rhetorical one.

VendorInvestigate does not measure anything and you have grouped it with three laboratories under the heading independent testing. That is exactly the conflation your article says the market makes.

Your section on sampling should mention the sealed vial. A laboratory that receives a factory-sealed container and breaks the seal itself can say something about what was in the container. One that receives a decanted aliquot in a plain tube can say something about the tube.

Treating the four services as institutions rather than as brands is the right frame and it exposes how thin the institutional layer is. Four organisations, no common reporting standard, no shared reference material and no mechanism by which one can be compared with another except by a buyer paying twice.

Stopper choice belongs in this section. A stopper that has not been properly dried will release water into the headspace over months, and a cake that left the plant at one per cent moisture will not still be at one per cent when it arrives. The container is part of the formulation.

Your description of collapse is right and the consequence is worth spelling out. A collapsed cake has a lower surface area and reconstitutes more slowly, and it also indicates the product went above its collapse temperature during primary drying. It is a visible record of a process deviation, sitting in the vial where anybody can see it.

pH is the strongest lever on most of these pathways and it is set by a buffer the buyer did not choose and cannot see. The most important stability variable in the vial is undisclosed.

The most useful thing this department could publish is a plain statement of what is and is not known about in-use stability for this class, with the sources. The absence of such a statement is why the folklore has filled the space.

Badge and product are separated by a layer of navigation on most sites I visit. The badge sits in the footer, the product is on a different page, and the association a buyer draws between them is entirely their own work.

The services could fix this unilaterally by serving badge images from their own infrastructure with the date rendered server-side. It is a fortnight of work, it costs a seller nothing, and it removes the possibility of a stale image entirely.

The relevant literature here is nursing and pharmacy practice rather than anything specific to this market, and it is freely available. Almost nobody discussing this subject has read any of it.

Aseptic technique is a set of behaviours with a defined purpose and it is described in this market as a list of products to buy. The purpose is to avoid introducing organisms at a defined set of moments, and knowing which moments matters more than any consumable.

The section on in-use stability is unhelpfully agnostic. Everyone in this market uses a figure of around thirty days refrigerated. Surely you can say whether that is roughly right rather than declining to comment.

Lipohypertrophy is the outcome rotation actually prevents, and it develops over months of repeated use of one small area. It is a slow, quiet problem, and by the time it is visible it has been forming for a long time.

Displacement is small for these quantities and not always negligible. Adding 2 mL of diluent to a vial containing a few milligrams of solid gives very slightly more than 2 mL of solution. It is a fraction of a per cent and it is worth knowing that the direction of the error is always the same.

Attrition produces apparent plateaus mechanically. If people whose trajectory flattens leave the study at a different rate from those whose does not, the remaining group mean moves for reasons that have nothing to do with anybody’s response.

Nobody has published what happens to intake over the course of these trials, though several must have collected it. A plateau explained by intake returning toward baseline is a different phenomenon from one explained by anything pharmacological.

The trial protocols permitted holding and delay, which is a point that gets lost. The schedules people treat as rigid were operated with discretion in the studies that produced the evidence, and the protocols say so in the escalation sections.

Batch record and certificate answer different questions. The certificate says what a sample measured; the record says what the process did. A supplier that will send the second is offering a different kind of transparency from one that reissues the first on request.

We started photographing the vial, the label and the seal before sending anything for testing, and it has settled two disputes since. It costs a minute and it converts a claim about provenance into a record of it.

You describe reused chromatogram images as a tell. I work in a contract laboratory and I would note that some data systems export a representative overlay rather than the individual injection, so identical-looking traces can occur legitimately across a batch series. It is still worth asking about; it is not the smoking gun your article implies.

Water content by Karl Fischer is inexpensive, fast and almost never reported. For a lyophilised powder it bears directly on stability, and it is the determination I would add first if I could add only one. Material described as being for research use only is not approved for human use in any case, so the argument for measuring it is a scientific one rather than a safety one.

Please continue to state plainly what has not been established. It is the part of your reporting I have come to rely on most.

Your worked example separates two species one dalton apart and treats that as the hard case. The hard case in practice is fourteen milli-daltons, which is what distinguishes a genuine methyl group from a substitution nobody wanted. That gap needs an order of magnitude more resolving power than most service instruments deliver.

A caution on the word high-resolution as it appears in marketing. It is not a threshold; it is a continuum, and instruments separated by a factor of twenty in resolving power are sold under the same adjective. Ask for the figure and the mass at which it was obtained, and the adjective becomes unnecessary.

Ask for the acquisition method file, not the report. The report is a rendering of a decision; the method file is the decision. Two laboratories will send you the same one-page summary from acquisitions that have almost nothing in common.

Your article says a matching mass does not confirm a sequence, which is correct, and then rather implies that vendors are trading on the ambiguity. I run analytical services and I would put it differently: we report what we measured, in the words our clients ask for. If the Journal wants the word confirmed retired, write to the buyers, not to us.

The instrument-class section is the most useful thing you have printed on this subject. A unit-resolution quadrupole cannot distinguish a deamidation from the parent, and a great many identity confirmations in this trade are performed on exactly that class of instrument. The report says the mass matched, and it did, at the resolution available.

The number worth asking for is resolving power at the mass you care about, not the headline figure from the brochure. Instruments are specified at a mass convenient to the manufacturer, and a peptide at four thousand daltons is not that mass. Ask where the specification was measured.

You state that fourteen of twenty suppliers report an MS identity test. Does that count reports supplied to you on request, or only what appears on the certificate a customer receives?

Two ionisation techniques on the same sample is the cheapest confidence a laboratory can buy. Electrospray and matrix-assisted desorption fail in different directions, and a species that survives both is far more likely to be real than one that appears only in the technique the laboratory happens to own.

Reasons collected by a supplier, a clinician and a researcher would produce three different distributions from the same population, because people say different things to different audiences. Every dataset in this area is an artefact of who was asking.

The reason I have most often encountered is a simple one and appears in no list: it was always meant to be temporary. Somebody who set out to stop and then stopped has not discontinued in any interesting sense, and they are counted alongside those who did.

A point about measurement. People maintaining a position tend to weigh less often, so the data thins exactly where it would be most informative. The apparent stability of the maintenance phase in self-reported series is partly an artefact of who is still measuring.

Frequency deserves a word. Repeating a panel monthly during a period of change produces a series in which most movement is variation rather than trend, and reading each report as news is a recipe for chasing noise.

Timing consistency is undervalued. Same laboratory, same time of day, same fasting state removes a large part of the noise between draws for no cost whatever, and it makes a modest true change visible that would otherwise be buried.